tradingkey.logo
tradingkey.logo
Search

Genmab A/S

GMAB
Add to Watchlist
35.220USD
+0.530+1.53%
Close 09-22 16:00ET
21.64BMarket Cap
26.54P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.53%

5 Days

+3.13%

1 Month

+5.29%

6 Months

+40.32%

Year to Date

+14.35%

1 Year

+23.15%

Key Figures

34.460Open
35.295High
241.41KVolume
26.54P/E TTM
18.86P/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
34.690Prev. Close
34.370Low
8.46MTurnover
19.02P/E Static
3.63P/B
0.00%Div Yield TTM
8.66%ROA
35.43052wk High
36.31Volume Ratio
1.14BNet Profit
614.38MShares
1.3275EPS TTM
0.87Beta
14.96%ROE
23.62052wk Low
2.58%Amplitude
92.74%Gross Margin
21.64BMarket Cap
9.86Reward/Risk
2.12%Risk Rate
More news coming soon, stay tuned...

Genmab A/S's Score

0.00vs previous score
Forecast8.86
Financial Health8.31
Technical3.01
Valuation Dimensions9.46
Institutional Confidence3.00
Risk Assessment7.93

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
40.000Target Price
+15.14%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy78776554
Buy65543333
Hold12233222
Sell00000000
Strong Sell00000000

Genmab A/S Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.49/0.35
Revenue / Forecast
1.16B/1.11B

Genmab A/S Profile

SectorBiotechnology & Medical Research
Ticker SymbolGMAB
Number of employees2682
CountryDenmark

Ownership

ShareholdersProportion
Orbis Investment Management Ltd.2.35%
AllianceBernstein L.P.1.77%
Paradigm BioCapital Advisors LP1.15%
Arrowstreet Capital, Limited Partnership0.81%
Shareholder TypesProportion
Investment Advisor/Hedge Fund5.75%
Investment Advisor3.72%
Hedge Fund2.33%
Research Firm0.24%

FAQs

What is the current price of Genmab A/S (GMAB)?

The current price of Genmab A/S (GMAB) is 35.22.

What is the symbol of Genmab A/S?

The ticker symbol of Genmab A/S is GMAB.

What is the 52-week high of Genmab A/S?

The 52-week high of Genmab A/S is 35.43.

What is the 52-week low of Genmab A/S?

The 52-week low of Genmab A/S is 23.62.

What is the market capitalization of Genmab A/S?

The market capitalization of Genmab A/S is 21.64B.

Is Genmab A/S (GMAB) currently rated as Buy, Hold, or Sell?

According to analysts, Genmab A/S (GMAB) has an overall rating of Buy, with a price target of 40.00.

What is the Earnings Per Share (EPS TTM) of Genmab A/S (GMAB)?

The Earnings Per Share (EPS TTM) of Genmab A/S (GMAB) is 1.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.